Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PAF acetylhydrolase gene polymorphisms and asthma severity.

D M Stafforini1

  • 1Huntsman Cancer Institute, 2000 Circle of Hope, University of Utah, Salt Lake City, UT 84112-5550, USA. diana.stafforini@hci.utah.edu

Pharmacogenomics
|September 6, 2001
PubMed
Summary

Genetic variations in platelet-activating factor (PAF) acetylhydrolase influence asthma development by affecting lipid mediator levels. Understanding these genetic factors is crucial for asthma research and potential therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diacylglycerol kinase η modulates oncogenic properties of lung cancer cells.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
Same author

Characterization of human UMP-CMP kinase enzymatic activity and 5' untranslated region.

Life sciences·2001
Same author

Platelet-activating factor acetylhydrolases in health and disease.

Biochimica et biophysica acta·2000
Same author

Platelet-activating factor and related lipid mediators.

Annual review of biochemistry·2000
Same author

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.

The Journal of clinical investigation·1999
Same author

Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.

The Journal of biological chemistry·1999

Area of Science:

  • Biochemistry
  • Genetics
  • Immunology

Background:

  • Platelet-activating factor (PAF) and oxidized phosphatidylcholines are implicated in asthma pathogenesis.
  • PAF acetylhydrolase inactivates these pro-inflammatory lipid mediators.
  • The enzyme's function is influenced by its association with lipoproteins and oxidative stress.

Purpose of the Study:

  • To review the role of genetic alterations in PAF acetylhydrolase in asthma.
  • To explore the biochemical and clinical implications of PAF acetylhydrolase variations.
  • To discuss the impact of genetic factors on lipid mediator levels in asthma.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of biochemical, structural, and functional characteristics of PAF acetylhydrolase.

Related Experiment Videos

  • Examination of genetic mutations and polymorphisms in asthmatic populations.

    • Main Results:

    • PAF acetylhydrolase activity is modulated by lipoproteins and oxidative inactivation.
    • Inflammatory mediators can alter PAF acetylhydrolase expression transcriptionally.
    • Naturally occurring variants of PAF acetylhydrolase exhibit altered catalytic properties.

    Conclusions:

    • Genetic factors, including mutations and polymorphisms, contribute to asthma pathogenesis by influencing lipid mediator levels.
    • PAF acetylhydrolase plays a significant role in modulating inflammatory responses in asthma.
    • Further research into PAF acetylhydrolase genetics is warranted for understanding complex asthma.